ERK Cancer Research Results

ERK, ERK signaling: Click to Expand ⟱
Source:
Type:
MAPK3 (ERK1)
ERK proteins are kinases that activate other proteins by adding a phosphate group. An overactivation of these proteins causes the cell cycle to stop.
The extracellular signal-regulated kinase (ERK) signaling pathway is a crucial component of the mitogen-activated protein kinase (MAPK) signaling cascade, which plays a significant role in regulating various cellular processes, including proliferation, differentiation, and survival. high levels of phosphorylated ERK (p-ERK) in tumor samples may indicate active ERK signaling and could correlate with aggressive tumor behavior

EEk singaling is frequently activated and is often associated with aggressive tumor behavior, treatment resistance, and poor outcomes.


Scientific Papers found: Click to Expand⟱
2598- Ba,    Baicalein inhibits melanogenesis through activation of the ERK signaling pathway
- in-vitro, Melanoma, B16-F10
other↓, other?, ERK↑,
2597- Ba,    Baicalein – An Intriguing Therapeutic Phytochemical in Pancreatic Cancer
- Review, PC, NA
chemoP↑, ChemoSen↑, 12LOX?, Bcl-2↓, BAX↑, Mcl-1↓, ERK↓, Prx6↑, Dose↝, BioAv↓, eff↑,
2624- Ba,    Baicalein inhibition of hydrogen peroxide-induced apoptosis via ROS-dependent heme oxygenase 1 gene expression
- in-vitro, Nor, RAW264.7
*HO-1↑, *ERK↑, *ROS↓, *eff↑, *MMP↑, *Cyt‑c∅,
2627- Ba,  Cisplatin,    Baicalein, a Bioflavonoid, Prevents Cisplatin-Induced Acute Kidney Injury by Up-Regulating Antioxidant Defenses and Down-Regulating the MAPKs and NF-κB Pathways
- in-vivo, Var, NA
RenoP↑, *iNOS↑, *TNF-α↓, *IL6↓, *NF-kB↓, *MAPK↓, *ERK↓, *JNK↓, *antiOx↑, *NRF2↓, *HO-1↑, *Cyt‑c∅, *Casp3∅, *Casp9∅, *PARP∅,
5547- BBM,    Berbamine exerts anticancer effects on human colon cancer cells via induction of autophagy and apoptosis, inhibition of cell migration and MEK/ERK signalling pathway
- in-vitro, CRC, HT29
tumCV↓, selectivity↑, Casp3↑, Casp9↑, Bax:Bcl2↑, ATG5↑, Beclin-1/ATG6↑, TumCP↓, MEK↓, ERK↓,
5549- BBM,    Synergistic Anticancer Effect of a Combination of Berbamine and Arcyriaflavin A against Glioblastoma Stem-like Cells
- in-vitro, GBM, NA
eff?, tumCV↓, TumCG↓, ROS↑, P53↑, CSCs↓, CD133↓, ALDH1A1↓, Nanog↓, SOX2↓, OCT4↓, CDK1↓, CaMKII ↓, STAT3↓, Akt↓, ERK↓,
1242- BBM,    Berbamine Exerts Anti-Inflammatory Effects via Inhibition of NF-κB and MAPK Signaling Pathways
- in-vivo, Nor, NA
*Macrophages↓, *Neut↓, *p‑NF-kB↓, *p‑MAPK↓, *p‑JNK↓, *p‑ERK↓,
2021- BBR,    Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways
- Review, Var, NA
*antiOx?, *Inflam↓, Apoptosis↑, TumCCA↑, BAX↑, Synergy↑, VEGF↓, PI3K↓, Akt↓, mTOR↓, Telomerase↓, β-catenin/ZEB1↓, Wnt↓, EGFR↓, AP-1↓, NF-kB↓, COX2/PTGS2↑, NRF2↓, RadioS↑, STAT3↓, ERK↓, AR↓, ROS↑, eff↑, selectivity↑, selectivity↑, BioAv↓, DNMT1↓, cMyc↓,
1395- BBR,    Analysis of the mechanism of berberine against stomach carcinoma based on network pharmacology and experimental validation
- in-vitro, GC, NA
Apoptosis↑, ROS↑, MMP↓, ATP↓, AMPK↑, TP53↑, p‑MAPK↓, p‑ERK↓,
1390- BBR,  Rad,    Berberine Inhibited Radioresistant Effects and Enhanced Anti-Tumor Effects in the Irradiated-Human Prostate Cancer Cells
- in-vitro, Pca, PC3
RadioS↑, Apoptosis↑, ROS↑, eff↑, BAX↑, Casp3↑, P53↑, p38↑, JNK↑, Bcl-2↓, ERK↓, HO-1↓,
1299- BBR,    Effects of Berberine and Its Derivatives on Cancer: A Systems Pharmacology Review
- Review, Var, NA
TumCCA↑, TP53↑, COX2/PTGS2↓, Bax:Bcl2↑, ROS↑, VEGFR2/KDR/Flk1↓, Akt↓, ERK↓, MMP2↓, MMP9↓, IL8↑, P21↑, p27/CDKN1B↑, E-cadherin↓, Fibronectin↓, cMyc↓,
1382- BBR,    Berberine increases the expression of cytokines and proteins linked to apoptosis in human melanoma cells
- in-vitro, Melanoma, SK-MEL-28
Apoptosis↑, necrosis↑, DNAdam↑, TumCCA↑, ROS↑, Casp3↑, p‑P53↑, ERK↑,
2694- BBR,    Berberine down-regulates IL-8 expression through inhibition of the EGFR/MEK/ERK pathway in triple-negative breast cancer cells
- in-vitro, BC, NA
IL8↓, TumCI↓, EGFR↓, MEK↓, ERK↓, TGF-β1↓, VEGF↓,
2693- BBR,    Antitumor Effects of Berberine on Gliomas via Inactivation of Caspase-1-Mediated IL-1β and IL-18 Release
- in-vitro, GBM, U251 - in-vitro, GBM, U87MG
Casp1↓, ERK↓, IL1β↓, IL18↓, EMT↑,
2691- BBR,    Berberine induces FasL-related apoptosis through p38 activation in KB human oral cancer cells
- in-vitro, Oral, KB
tumCV↓, DNAdam↑, Casp3↑, Casp7↑, FasL↑, Casp8↑, Casp9↑, PARP↑, BAX↑, BAD↑, APAF1↑, MMP2↓, MMP9↓, p‑p38↑, ERK↑, MAPK↑,
2690- BBR,    Berberine Differentially Modulates the Activities of ERK, p38 MAPK, and JNK to Suppress Th17 and Th1 T Cell Differentiation in Type 1 Diabetic Mice
- in-vivo, Diabetic, NA
*Inflam↓, *Th17↓, *Th1 response↓, *ERK↑, *p38↓, *JNK↓, *STAT1↓, *STAT4↓, *MAPK↓,
2670- BBR,    Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases
- Review, Var, NA
*Inflam↓, *antiOx↑, *Ca+2↓, *BioAv↓, *BioAv↑, *BioAv↑, *angioG↑, *MAPK↓, *AMPK↓, *NF-kB↓, VEGF↓, PI3K↓, Akt↓, MMP2↓, Bcl-2↓, ERK↓,
2674- BBR,    Berberine: A novel therapeutic strategy for cancer
- Review, Var, NA - Review, IBD, NA
Inflam↓, AntiCan↑, Apoptosis↑, TumAuto↑, TumCCA↑, TumMeta↓, TumCI↓, eff↑, eff↑, CD4+↓, TNF-α↓, IL1↓, BioAv↓, BioAv↓, other↓, AMPK↑, MAPK↓, NF-kB↓, IL6↓, MCP1/CCL2↓, PGE2↓, COX2/PTGS2↓, *ROS↓, *antiOx↑, *GPx↑, *Catalase↑, AntiTum↑, TumCP↓, angioG↓, Fas↑, FasL↑, ROS↑, ATM↑, P53↑, RB1↑, Casp9↑, Casp8↑, Casp3↓, BAX↑, Bcl-2↓, Bcl-xL↓, IAP1↓, XIAP↓, survivin↓, MMP2↓, MMP9↓, CycB/CCNB1↓, CDC25↓, CDC25↓, Cyt‑c↑, MMP↓, RenoP↑, mTOR↓, MDM2↓, LC3II↑, ERK↓, COX2/PTGS2↓, MMP3↓, TGF-β↓, EMT↑, ROCK1↓, FAK↓, RAS↓, Rho↓, NF-kB↓, uPA↓, MMP1↓, MMP13↓, ChemoSen↑,
2686- BBR,    Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
- Review, Nor, NA
Inflam↓, IL6↓, MCP1/CCL2↓, COX2/PTGS2↓, PGE2↓, MMP2↓, MMP9↓, DNAdam↑, eff↝, Telomerase↓, Bcl-2↓, AMPK↑, ROS↑, MMP↓, ATP↓, p‑mTORC1↓, p‑S6K↓, ERK↓, PI3K↓, PTEN↑, Akt↓, Raf↓, MEK↓, Dose↓, Dose↑, selectivity↑, TumCCA↑, Synergy↑, EGFR↓, Glycolysis↓, Dose?, p27/CDKN1B↑, CDK2↓, CDK4↓, cycD1/CCND1↓, cycE/CCNE↓, Bax:Bcl2↑, Casp3↑, Casp9↑, VEGFR2/KDR/Flk1↓, ChemoSen↑, Synergy↑, Synergy↑, PGE2↓, JAK2↓, STAT3↓, CXCR4↓, CCR7↓, uPA↓, CSCs↓, EMT↓, Diff↓, CD133↓, Nestin↓, n-MYC↓, NOTCH↓, SOX2↓, Hif1a↓, VEGF↓, RadioS↑,
3678- BBR,    Network pharmacology study on the mechanism of berberine in Alzheimer’s disease model
- Review, AD, NA
*APP↓, *PPARγ↑, *NF-kB↓, *Aβ↓, *cognitive↑, *antiOx↑, *Inflam↓, *Apoptosis↓, *BioAv↑, *BioAv↝, *BBB↑, *motorD↑, *NRF2↑, *HO-1↑, *ROS↓, *p‑Akt↑, *p‑ERK↑,
3680- BBR,    Network pharmacology reveals that Berberine may function against Alzheimer’s disease via the AKT signaling pathway
- in-vivo, AD, NA
*Akt↑, *neuroP↑, *p‑ERK↑, *Aβ↓, *Inflam↓, *ROS↓, *BioAv↑, *BBB↑, *Half-Life↝, *memory↑, *cognitive↑, *HSP90↑, *APP↓, *mTOR↓, *P70S6K↓, *CD31/PECAM-1↑, *VEGF↑, *N-cadherin↑, *Apoptosis↓,
5182- BBR,    Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-κB, u-PA and MMP-2 and -9
- in-vitro, SCC, SCC4
TumCMig↓, TumCI↓, p‑JNK↝, p‑ERK↝, p‑p38↝, IKKα↝, NF-kB↝, MMP2↓, MMP9↓,
5180- BBR,    Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth
- in-vitro, NSCLC, NA
TumCMig↓, TumCP↓, Apoptosis↑, TFAP2A↓, hTERT/TERT↓, NF-kB↓, COX2/PTGS2↓, Hif1a↓, VEGF↓, Akt↓, p‑ERK↓, Cyt‑c↑, cl‑Casp↑, cl‑PARP↑, PI3K↓, Akt↓, Raf↓, MEK↓, ERK↓,
1473- BCA,  SFN,    An Insight on Synergistic Anti-cancer Efficacy of Biochanin A and Sulforaphane Combination Against Breast Cancer
- in-vitro, BC, MCF7
eff↑, ROS↑, other↑, ERK↓, Apoptosis↑,
6495- BCP,    Beta-caryophyllene is a dietary cannabinoid
- Study, Nor, NA
*CB2 / CNR2↑, *other↝, *Inflam↓, *TNF-α↓, *IL1β↓, *ERK↓, *JNK↓,
6503- BCP,    The Potential Therapeutic Role of Beta-Caryophyllene as a Chemosensitizer and an Inhibitor of Angiogenesis in Cancer
- Review, Var, NA
ChemoSen↑, angioG↓, TumCI↓, TumMeta↓, ROS↑, *ROS↓, chemoP↑, CB2 / CNR2↑, Inflam↓, AntiTum↑, *BioAv↑, *BBB↑, Apoptosis↑, TumCP↑, TumCCA↑, RadioS↑, DNArepair↓, ROS↑, STAT3↓, *BioEnh↑, Pain↓, AntiBio↓, ROS↑, Dose↝, NF-kB↓, MAPK↓, TNF-α↓, IL1β↓, IL6↓, cl‑PARP↑, Casp↑, BAX↑, Bcl-2↓, VEGF↓, VEGFR2/KDR/Flk1↓, MMP2↓, p‑p38↓, p‑ERK↓, EPR↑, P-gp/ABCB1↓, MRP1/ABCC1↓, *NRF2↑, *antiOx↑,
2758- BetA,    Betulinic Acid Attenuates Oxidative Stress in the Thymus Induced by Acute Exposure to T-2 Toxin via Regulation of the MAPK/Nrf2 Signaling Pathway
- in-vivo, Nor, NA
*ROS↓, *MDA↓, *SOD↑, *GSH↑, *p‑p38↓, *p‑JNK↓, *p‑ERK↓, *NRF2↑, *HO-1↑, *MAPK↓, *heparanase↑, *antiOx↑,
2760- BetA,    A Review on Preparation of Betulinic Acid and Its Biological Activities
- Review, Var, NA - Review, Stroke, NA
AntiTum↑, Cyt‑c↑, Smad1↑, Sepsis↓, NF-kB↓, ICAM-1↓, MCP1/CCL2↓, MMP9↓, COX2/PTGS2↓, PGE2↓, ERK↓, p‑Akt↓, *ROS↓, *LDH↓, *hepatoP↑, *SOD↑, *Catalase↑, *GSH↑, *AST↓, *ALAT↓, *RenoP↑, *ROS↓, *α-SMA↓,
9205- BITC,    Benzyl Isothiocyanate (BITC) Inhibits Migration and Invasion of Human Colon Cancer HT29 Cells by Inhibiting Matrix Metalloproteinase-2/-9 and Urokinase Plasminogen (uPA) through PKC and MAPK Signaling Pathway
- in-vitro, CRC, HT-29
TumCMig↓, TumCI↓, MMP2↓, uPA↓, p‑JNK↓, p‑ERK↓, PI3K↓, PKCδ↓, cFos↓, cJun↓, RAS↓, FAK↓, GRB2↓,
9171- BITC,    Benzyl Isothiocyanate potentiates p53 signaling and antitumor effects against breast cancer through activation of p53-LKB1 and p73-LKB1 axes
- in-vitro, BC, MDA-MB-231 - in-vitro, BC, MCF7
p‑P53↑, Apoptosis↑, cl‑PARP↑, Ki-67↓, survivin↓, XIAP↓, p‑ERK↑, p‑CREB↑, MDM2↑,
9163- BITC,    Benzyl isothiocyanate-mediated generation of reactive oxygen species causes cell cycle arrest and induces apoptosis via activation of MAPK in human pancreatic cancer cells
- in-vitro, PC, Capan1
Apoptosis?, p‑ERK↑, JNK↑, ROS↑, GSH↓, eff↓, BAX↑, cl‑Casp3↑, cl‑PARP↑, selectivity↑,
9199- BITC,    Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways
- in-vitro, GC, NA
TumCMig↓, TumCI↓, ERK↓, RAS↓, GRB2↓, Rho↓, iNOS↓, COX2/PTGS2↓, MMP2↓, MMP7↓, MMP9↓,
5482- BM,    Bacopa monnieri protects SH-SY5Y cells against tert-Butyl hydroperoxide-induced cell death via the ERK and PI3K pathways
- in-vitro, Nor, NA
*neuroP↑, *ERK↑, *Akt↑, *MAPK↑, *PI3K↑, *Inflam↓, antiOx↑,
5680- BML,    Anticancer properties of bromelain: State-of-the-art and recent trends
- Review, Var, NA
*Inflam↓, *Bacteria↓, *Pain↓, *Diar↓, *Wound Healing↑, ERK↓, JNK↓, XIAP↓, HSP27↓, β-catenin/ZEB1↓, HO-1↓, lipid-P↓, ACSL4↑, ROS↑, SOD↑, Catalase↓, GSH↓, MDA↓, Casp3↓, Casp9↑, DNAdam↑, Apoptosis↑, NF-kB↓, P53↑, MAPK↓, APAF1↑, Cyt‑c↓, CD44↓, Imm↑, ATG5↑, LC3I↑, Beclin-1/ATG6↑, IL2↓, IL4↓, IFN-γ↓, COX2/PTGS2↓, iNOS↓, ChemoSen↑, RadioS↑, Dose↝, other↓,
5683- BML,    Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway
- in-vitro, Melanoma, NA
COX2/PTGS2↓, MAPK↓, NF-kB↓, TumMeta↓, P53↑, BAX↑, Casp3↑, Casp9↑, Bcl-2↓, MAPK↓, ERK↓, Akt↓, TumVol↓,
709- Bor,    Cellular changes in boric acid-treated DU-145 prostate cancer cells
- in-vitro, Pca, DU145
Cyc↓, MAPK↓, TumCMig↓, LAMP2↓, p‑ERK⇅, TumCM/A↑,
726- Bor,    Redox Mechanisms Underlying the Cytostatic Effects of Boric Acid on Cancer Cells—An Issue Still Open
- Review, Var, NA
NAD↝, SAM-e↝, PSA↓, IGF-1↓, Cyc↓, P21↓, p‑MEK↓, p‑ERK↓, ROS↑, SOD↓, Catalase↓, MDA↑, GSH↓, IL1↓, IL6↓, TNF-α↓, BRAF↝, MAPK↝, PTEN↝, PI3K/Akt↝, eIF2α↑, ATF4↑, ATF6↑, NRF2↑, BAX↑, BID↑, Casp3↑, Casp9↑, Bcl-2↓, Bcl-xL↓,
2776- Bos,    Anti-inflammatory and anti-cancer activities of frankincense: Targets, treatments and toxicities
- Review, Var, NA
*5LO↓, *TNF-α↓, *MMP3↓, *COX1↓, *COX2/PTGS2↓, *PGE2↓, *Th2↑, *Catalase↑, *SOD↑, *NO↑, *PGE2↑, *IL1β↓, *IL6↓, *Th1 response↓, *Th2↑, *iNOS↓, *NO↓, *p‑JNK↓, *p38↓, GutMicro↑, p‑Akt↓, GSK‐3β↓, cycD1/CCND1↓, Akt↓, STAT3↓, CSCs↓, AR↓, P21↑, DR5↑, CHOP/DDIT3↑, Casp3↑, Casp8↑, cl‑PARP↑, DNAdam↑, p‑RB1↓, FOXM1↓, TOP2↓, CDC25↓, p‑CDK1↓, p‑ERK↓, MMP9↓, VEGF↓, angioG↓, ROS↑, Cyt‑c↑, AIF↑, Diablo↑, survivin↓, ICAD↓, ChemoSen↑, SOX9↓, ER Stress↑, GRP78/BiP↑, cal2↓, AMPK↓, mTOR↓, ROS↓, *antiAll↑,
2775- Bos,    The journey of boswellic acids from synthesis to pharmacological activities
- Review, Var, NA - Review, AD, NA - Review, PSA, NA
ROS↑, ER Stress↑, TumCG↓, Apoptosis↑, Inflam↓, ChemoSen↑, Casp↑, ERK↓, cl‑PARP↑, AR↓, cycD1/CCND1↓, VEGFR2/KDR/Flk1↓, CXCR4↓, radioP↑, NF-kB↓, VEGF↓, P21↑, Wnt↓, β-catenin/ZEB1↓, Cyt‑c↑, MMP2↓, MMP1↓, MMP9↓, PI3K↓, MAPK↓, JNK↑, *5LO↓, *NRF2↑, *HO-1↑, *MDA↓, *SOD↑, *hepatoP↑, *ALAT↓, *AST↓, *LDH↑, *CRP↓, *COX2/PTGS2↓, *GSH↑, *ROS↓, *Imm↑, *Dose↝, *eff↑, *neuroP↑, *cognitive↑, *IL6↓, *TNF-α↓, *AntiArt↑, *AntiDiabetic↑, *antiAll↑,
2767- Bos,    The potential role of boswellic acids in cancer prevention and treatment
- Review, Var, NA
*Inflam↓, AntiCan↑, *MAPK↑, *Ca+2↝, p‑ERK↓, TumCI↓, cycD1/CCND1↓, cycE/CCNE↓, CDK2↓, CDK4↓, p‑RB1↓, *NF-kB↓, *TNF-α↓, NF-kB↓, IKKα↓, MCP1/CCL2↓, IL1α↓, MIP2↓, VEGF↓, Tf↓, COX2/PTGS2↓, MMP9↓, CXCR4↓, VEGF↓, Synergy↑, PPARα↓, lipid-P?, STAT3↓, TOP1↓, TOP2↑, 5HT↓, p‑PDGFR-BB↓, PDGF↓, AR↓, DR5↑, angioG↓, DR4↑, Casp3↑, Casp8↑, cl‑PARP↑, eff↑, chemoPv↑, Wnt↓, β-catenin/ZEB1↓, ascitic↓, Let-7↑, miR-200b↑, Synergy↑, MMP1↓, MMP2↓, Synergy↑, BioAv↓, BioAv↑, Half-Life↓, toxicity↓, Dose↑, BioAv↑, ChemoSen↑, *antiAll↑,
8973- BRice,    Suppression of Inflammatory Responses by Black Rice Extract in RAW 264.7 Macrophage Cells via Downregulation of NF-kB and AP-1 Signaling Pathways
- in-vitro, Nor, RAW264.7
*Ingr↝, *Inflam↓, *NO↓, *iNOS↓, *COX2/PTGS2↓, *TNF-α↓, *IL6↓, *NF-kB↓, *AP-1↓, *p‑ERK↓, *p‑p38↓, *p‑JNK↓, *MAPK↓,
5693- BRU,    Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2
- in-vivo, HCC, NA
NRF2↓, eff↑, p‑MAPK↑, p‑Akt↑, p‑ERK↑, p‑JNK↑,
6553- BSB,    Pharmacological and biological effects of alpha-bisabolol: An updated review of the molecular mechanisms
- Review, Nor, NA
*ROS↓, *Inflam↓, *Inf↓, *neuroP↑, *RNS↓, *MDA↓, *GSH↑, *MPO↓, *SOD↑, *Catalase↑, *Bcl-2↑, *BAX↓, *P53↓, *APAF1↓, *Casp3↓, *Casp9↓, *TNF-α↓, *IL1β↓, *IL6↓, *iNOS↓, *COX2/PTGS2↓, *ERK↓, *JNK↓, *NF-kB↓, *p38↓, *cognitive↑, *BChE↓,
1651- CA,  PBG,    Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer
- Review, Var, NA
Apoptosis↑, TumCCA↓, TumCMig↓, TumMeta↓, ChemoSen↑, eff↑, Synergy↑, eff↓, eff↝, Dose∅, AMPK↑, p62↓, LC3II↑, Ca+2↑, Bax:Bcl2↑, CDK4↑, CDK6↑, RB1↑, EMT↓, E-cadherin↑, Vim↓, β-catenin/ZEB1↓, NF-kB↓, angioG↑, VEGF↓, TSP-1↑, MMP9↓, MMP2↓, ChemoSen↑, Synergy↑, ROS↑, CSCs↓, Fas↑, P53↑, BAX↑, Casp↑, β-catenin/ZEB1↓, NDRG1↑, STAT3↓, MAPK↑, ERK↑, Synergy↑, Synergy↑, Synergy↑,
1652- CA,    Caffeic Acid and Diseases—Mechanisms of Action
- Review, Var, NA
Dose∅, ROS⇅, NF-kB↓, STAT3↓, VEGF↓, MMP9↓, HSP70/HSPA5↑, AST↝, ALAT↝, ALP↝, Hif1a↓, IL6↓, IGF-1R↓, P21↑, iNOS↓, ERK↓, Snail↓, BID↑, BAX↑, Casp3↑, Casp7↑, Casp9↑, cycD1/CCND1↓, Vim↓, β-catenin/ZEB1↓, COX2/PTGS2↓, ROS↑,
1650- CA,    Adjuvant Properties of Caffeic Acid in Cancer Treatment
- Review, Var, NA
ROS↑, antiOx↑, Inflam↓, AntiCan↑, NF-kB↓, STAT3↓, ERK↓, ChemoSen↑, RadioS↑, AMPK↑, eff↑, selectivity↑, COX2/PTGS2↓, Dose∅, PHDs↓, MMP9↓, MMP2↓, Dose∅, Dose∅, Ca+2↑, Dose?, MMP↓, RadioS↑,
5750- CA,    Exploration of the anticancer properties of Caffeic Acid in malignant mesothelioma cells
- in-vitro, MM, NA
eff↑, selectivity↑, Ki-67↓, PCNA↓, TumCP↓, p‑ERK↓, Akt↓, p27/CDKN1B↑, P21↑, TumCCA↑, Bax:Bcl2↑, cl‑Casp3↑, mt-Apoptosis↑,
5747- CA,    Caffeic Acid Enhances Anticancer Drug-induced Apoptosis in Acid-adapted HCT116 Colon Cancer Cells
- in-vitro, CRC, NA
TumCP↓, Apoptosis↑, ChemoSen↑, PI3K↓, Akt↓, ERK↓,
5746- CA,    Caffeic acid hinders the proliferation and migration through inhibition of IL-6 mediated JAK-STAT-3 signaling axis in human prostate cancer
- in-vitro, Pca, PC3 - in-vitro, Pca, LNCaP
tumCV↓, ROS↑, TumCCA↑, Apoptosis↑, p‑MAPK↓, ERK↓, JNK↓, p38↓, IL6↓, JAK1↓, p‑STAT3↓, cycD1/CCND1↓, CDK1↓, BAX↑, Casp3↑, Bcl-2↓, TumCD↑,
5749- CA,  Z,  Rad,    Antitumor and Radiosensitizing Effects of Zinc Oxide-Caffeic Acid Nanoparticles against Solid Ehrlich Carcinoma in Female Mice
- vitro+vivo, BC, MCF7 - NA, Liver, HepG2
RadioS↑, TumVol↓, Bcl-2↓, NF-kB↓, VCAM-1↓, ERK↓, DNAdam↑, TumCCA↑,

Showing Research Papers: 51 to 100 of 437
Prev Page 2 of 9 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 437

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,  

Redox & Oxidative Stress(tgid=1) ⓘ

4-HNE↑, 1,   antiOx↓, 1,   antiOx↑, 10,   antiOx⇅, 1,   Catalase↓, 4,   Catalase↑, 1,   ENOX2↓, 1,   Fenton↑, 3,   GPx↓, 1,   GPx↑, 3,   GPx4↓, 4,   GSH↓, 21,   GSH↑, 4,   GSH/GSSG↓, 1,   GSR↑, 1,   GSTs↑, 1,   H2O2↑, 4,   HO-1↓, 8,   HO-1↑, 7,   HO-2↓, 1,   Iron↑, 3,   Keap1↓, 1,   lipid-P?, 1,   lipid-P↓, 7,   lipid-P↑, 7,   MDA↓, 2,   MDA↑, 3,   NOX4↓, 1,   NQO1↑, 1,   NRF2↓, 12,   NRF2↑, 10,   NRF2↝, 1,   Prx6↑, 1,   PYCR1↓, 1,   ROS?, 2,   ROS↓, 29,   ROS↑, 146,   ROS⇅, 8,   i-ROS↓, 1,   i-ROS↑, 2,   SAM-e↝, 1,   SOD↓, 6,   SOD↑, 6,   SOD1↑, 1,   SOD2↓, 1,   SOD2↑, 3,   Trx1↑, 1,   TrxR↓, 4,   TrxR1↓, 2,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTH1↓, 1,   IronCh↑, 3,   Tf↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

ADP:ATP↑, 1,   CDC2↓, 8,   CDC2↑, 1,   CDC25↓, 12,   CDC25↑, 1,   compI↓, 1,   compIII↓, 1,   compV↓, 1,   CS↓, 1,   EGF↓, 6,   ETC↓, 1,   HSP60/HSPD1↓, 1,   Insulin↓, 1,   mitResp↓, 2,   MKK7↓, 1,   mtDam↓, 1,   mtDam↑, 7,   OCR↓, 3,   OCR↑, 1,   OXPHOS↑, 1,   PDH↓, 1,   PDH↑, 1,   SIRT3↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX?, 1,   12LOX↓, 2,   5LO↓, 1,   ACC↑, 1,   ACLY↓, 1,   ACSL4↑, 1,   ALAT↓, 4,   ALAT↝, 1,   AMPK↓, 1,   AMPK↑, 18,   p‑AMPK↑, 1,   ATP↓, 14,   CAIX/CA9↓, 1,   cAMP⇅, 1,   ECAR↓, 2,   ECAR↝, 1,   FABP5/E-FABP↓, 1,   FAO↑, 1,   FASN↓, 5,   FASN↑, 1,   G6PD↓, 1,   GAPDH↓, 1,   glucose↝, 1,   GlucoseCon↓, 5,   glut↓, 1,   GlutaM↓, 1,   Glycolysis↓, 20,   GSK‐3β↓, 6,   GSK‐3β↑, 3,   p‑GSK‐3β↓, 4,   ac‑Histones↑, 1,   HK1↓, 1,   HK2↓, 11,   HMG-CoA↓, 1,   HSD17B4↓, 1,   lactateProd↓, 7,   lactateProd↑, 1,   LDHA↓, 2,   LDL↓, 1,   lipoGen↓, 1,   NAD↝, 1,   NADPH↓, 1,   O-Glc↓, 1,   PCK1↓, 1,   PDK1 / PDPK1?, 2,   PDK1 / PDPK1↓, 3,   p‑PDK1 / PDPK1↓, 1,   PFK↓, 1,   PFK1↓, 2,   PFK2↓, 1,   PKM2↓, 8,   PKM2↑, 1,   p‑PKM2↓, 1,   Pyruv↓, 1,   p‑S6↓, 2,   SIRT1↓, 4,   SIRT1↑, 5,   SIRT2↑, 1,   SREBP1/SREBF1↓, 1,   SREBP2↓, 1,   TCA↓, 1,   TumCM/A↓, 1,   TumCM/A↑, 1,   Warburg↓, 3,  

Cell Death(tgid=5) ⓘ

AIF↑, 8,   APAF1↑, 9,   Apoptosis?, 2,   Apoptosis↓, 6,   Apoptosis↑, 153,   mt-Apoptosis↑, 2,   ASK1↑, 1,   BAD↓, 2,   BAD↑, 8,   Bak↑, 7,   BAX↓, 2,   BAX↑, 101,   BAX↝, 1,   Bax:Bcl2↑, 27,   Bcl-2↓, 105,   Bcl-2↑, 6,   Bcl-xL↓, 20,   BID↓, 2,   BID↑, 7,   p‑BID↓, 1,   BIM↓, 1,   BIM↑, 6,   BNIP3↑, 2,   Casp↑, 21,   cl‑Casp↑, 1,   Casp1↓, 1,   Casp12?, 1,   Casp12↑, 1,   Casp2↑, 3,   Casp3↓, 6,   Casp3↑, 109,   cl‑Casp3↑, 22,   proCasp3↓, 1,   proCasp3↑, 1,   Casp6↑, 1,   Casp7↑, 13,   cl‑Casp7↑, 2,   Casp8↑, 34,   cl‑Casp8↑, 4,   Casp9↓, 1,   Casp9↑, 71,   cl‑Casp9↑, 9,   proCasp9↓, 1,   cFLIP↓, 7,   Cyt‑c↓, 1,   Cyt‑c↑, 67,   Cyt‑c↝, 2,   Diablo↑, 6,   DR5↑, 19,   Endon↑, 2,   FADD↑, 1,   Fas↑, 13,   FasL↑, 6,   FasL⇅, 1,   Ferroptosis↑, 7,   GranB/GZMB↑, 1,   GRP58↓, 1,   GSDME↑, 1,   IAP1↓, 5,   IAP2/BIRC3↓, 1,   cl‑IAP2/BIRC3↑, 1,   ICAD↓, 1,   iNOS↓, 17,   JWA↑, 1,   Mcl-1↓, 16,   p‑Mcl-1↓, 1,   MDM2↓, 8,   MDM2↑, 2,   p‑MDM2↓, 1,   Necroptosis↑, 3,   necrosis↑, 2,   NOXA↑, 2,   oncosis↑, 1,   p38↓, 16,   p38↑, 30,   p‑p38↓, 8,   p‑p38↑, 14,   p‑p38↝, 1,   Paraptosis↑, 1,   Perforin↑, 1,   PUMA↑, 2,   Pyro↑, 3,   RIP3↓, 1,   RIP3↑, 1,   survivin↓, 33,   TNFR 1↑, 2,   TRAIL↑, 6,   TRAILR↑, 1,   TumCD↑, 10,   XIAP↓, 16,   YAP/TEAD↓, 2,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 141,   Akt↑, 2,   Akt↝, 2,   Akt∅, 1,   p‑Akt↓, 51,   p‑Akt↑, 4,   AKT1↓, 1,   Akt2↓, 1,   BRAF↓, 1,   BRAF↝, 1,   CaMKII ↓, 1,   CaMKII ↑, 1,   CK2↓, 3,   cMET↓, 6,   p‑cMET↓, 1,   p‑cMET↑, 2,   CREB↓, 1,   p‑CREB↓, 1,   p‑CREB↑, 1,   cSrc↓, 3,   EGFR↓, 49,   p‑EGFR↓, 4,   EphB4↓, 1,   ERK↓, 203,   ERK↑, 43,   ERK↝, 4,   ERK∅, 1,   p‑ERK↓, 82,   p‑ERK↑, 25,   p‑ERK⇅, 2,   p‑ERK↝, 2,   e-ERK↑, 1,   FGFR1↓, 2,   FOXD3↑, 1,   GNAI1↓, 1,   GRB2↓, 2,   HER2/EBBR2↓, 9,   p‑HER2/EBBR2↓, 1,   HGF/c-Met↓, 2,   IGF-1R↓, 3,   IGFR↓, 2,   IKKα↓, 5,   IKKα↑, 2,   IKKα↝, 1,   p‑IKKα↓, 2,   IR↓, 1,   p‑IκB↓, 2,   JAK↓, 4,   p‑JAK↓, 1,   JAK1↓, 4,   JAK2↓, 12,   JNK↓, 14,   JNK↑, 38,   JNK↝, 1,   p‑JNK↓, 11,   p‑JNK↑, 15,   p‑JNK↝, 1,   cl‑JNK↑, 1,   MAP2K1/MEK1↓, 1,   p‑MAP2K1/MEK1↓, 1,   MAPK↓, 41,   MAPK↑, 23,   MAPK↝, 4,   p‑MAPK↓, 4,   p‑MAPK↑, 2,   MEK↓, 20,   MEK↑, 2,   p‑MEK↓, 6,   p‑MEK↑, 1,   MKK4↓, 1,   mTOR↓, 51,   p‑mTOR↓, 7,   mTORC2↓, 1,   p70S6↓, 1,   p‑p70S6↓, 1,   p‑p70S6↑, 1,   P70S6K↓, 6,   p‑P70S6K↓, 2,   p‑P90RSK↑, 1,   p‑PDGFR-BB↓, 1,   PI3K↓, 90,   PI3K↑, 1,   PI3K↝, 2,   p‑PI3K↓, 4,   PI3K/Akt↓, 5,   PI3K/Akt↑, 1,   PI3K/Akt↝, 1,   PI3k/Akt/mTOR↓, 2,   PIK3CA↓, 1,   p‑PIK3R1↓, 1,   PKCδ↓, 16,   PKCδ↑, 1,   p‑PKCδ↓, 1,   PP2A↑, 1,   PRAS40↑, 1,   PTEN↑, 21,   PTEN↝, 1,   p‑PTEN↓, 1,   PTK2B / PYK2↓, 1,   Raf↓, 12,   RAS↓, 18,   RAS↑, 1,   RIP1↓, 2,   RIP1↑, 1,   p‑RSK↓, 1,   S6K↓, 1,   p‑S6K↓, 1,   Sp1/3/4↓, 9,   Src↓, 2,   STAT↓, 3,   p‑STAT↓, 1,   STAT3↓, 54,   STAT3↝, 1,   p‑STAT3↓, 12,   p‑STAT3↑, 1,   STAT5↓, 1,   p‑STAT5↓, 1,   STAT6↓, 1,   THEM4/CTMP↑, 1,   TSC2↑, 2,  

Transcription & Epigenetics(tgid=7) ⓘ

ATF2↓, 1,   ATF3↑, 1,   ATF4↑, 6,   cJun↓, 7,   cJun↑, 1,   p‑cJun↓, 1,   p‑cJun↑, 2,   cMyc↓, 26,   p‑cMyc↑, 1,   DNMT1↓, 4,   DNMT3A↓, 1,   DNMTs↓, 3,   EZH2↓, 1,   FOXM1↓, 3,   FOXO↓, 1,   FOXO↑, 1,   FOXO1↓, 2,   FOXO1↑, 1,   FOXO3↓, 1,   FOXO3↑, 5,   p‑FOXO3↓, 1,   FOXO4↑, 2,   ac‑H3↑, 1,   ac‑H4↑, 1,   HATs↓, 2,   HATs↑, 2,   HDAC↓, 12,   HDAC1↓, 3,   HDAC2↓, 1,   HDAC4↓, 1,   HES1↓, 1,   HMTs↓, 1,   JPT1/HN1↓, 1,   LINC01116↓, 1,   miR-106b↓, 1,   miR-107↑, 1,   miR-10b-5p↓, 1,   miR-139-5p↑, 1,   miR-155↓, 2,   miR-182-5p↓, 1,   miR-200b↑, 2,   miR-203↓, 1,   miR-203↑, 1,   miR-21↓, 3,   miR-21↑, 1,   miR-210↓, 1,   miR-210↑, 1,   miR-22↑, 1,   miR-224↓, 1,   miR-29b↑, 1,   miR-340↓, 1,   miR-34a↑, 3,   miR-384↑, 1,   miR-422a↑, 1,   miR-590-3p↑, 1,   miR-592↑, 1,   MITF↓, 1,   Myc↓, 4,   n-MYC↓, 1,   NDRG1↑, 1,   OCT4↓, 5,   other?, 2,   other↓, 4,   other↑, 4,   other↝, 6,   SOX2↓, 4,   SOX4↓, 1,   SOX9↓, 1,   SUV39H↓, 1,   TCF-4↓, 1,   TFAP2A↓, 1,   tumCV↓, 46,  

Protein Folding & ER Stress(tgid=8) ⓘ

ATF6↑, 3,   cl‑ATF6↑, 2,   CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 19,   eIF2α↓, 2,   eIF2α↑, 5,   p‑eIF2α↑, 4,   ER Stress↓, 2,   ER Stress↑, 26,   Erlin1↑, 1,   GRP78/BiP↓, 1,   GRP78/BiP↑, 11,   GRP94↑, 2,   HSP27↓, 4,   HSP27↑, 1,   HSP27↝, 1,   HSP70/HSPA5↓, 5,   HSP70/HSPA5↑, 1,   HSP70/HSPA5↝, 1,   HSP72↓, 1,   HSP90↓, 5,   HSPs↓, 2,   IRE1↑, 2,   p‑IRE1↑, 1,   PERK↑, 4,   p‑PERK↑, 1,   SERPINH1/HSP47↓, 1,   UPR↑, 5,   XBP-1↓, 2,  

Autophagy & Lysosomes(tgid=9) ⓘ

ATG13↑, 1,   ATG16L1↑, 1,   ATG3↑, 1,   ATG5↑, 5,   ATG7↑, 3,   Beclin-1/ATG6↑, 12,   CTSB↓, 1,   CTSD↓, 1,   LAMP2↓, 1,   LC3‑Ⅱ/LC3‑Ⅰ↑, 1,   LC3B-II↑, 4,   LC3I↑, 1,   LC3II↓, 2,   LC3II↑, 10,   lysoMP↑, 1,   p62↓, 5,   p62↑, 3,   RUBCN↓, 1,   TumAuto↑, 31,   ULK1/ATG1↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

ATM↑, 3,   p‑ATM↑, 1,   p‑ATR↑, 1,   BRCA1↓, 2,   BRCA1↑, 1,   p‑BRCA1↑, 1,   BRCA2↓, 1,   DNAdam↓, 2,   DNAdam↑, 42,   DNArepair↓, 4,   ERCC3↑, 1,   HR↓, 1,   hTERT/TERT↓, 9,   p16↑, 2,   P53?, 1,   P53↓, 3,   P53↑, 59,   P53↝, 3,   P53∅, 1,   p‑P53↑, 5,   ac‑P53↑, 1,   PARP↓, 3,   PARP↑, 12,   p‑PARP↑, 2,   cl‑PARP↑, 60,   PARP1↑, 2,   cl‑PARP1↑, 2,   PCNA↓, 19,   RAD51↓, 1,   SAPK↑, 1,   SIRT6↑, 1,   Telomerase↓, 13,   TOP1↓, 4,   TOP2↓, 6,   TOP2↑, 1,   TP53↑, 2,   UHRF1↓, 1,   XRCC1↓, 1,   γH2AX↓, 1,   γH2AX↑, 4,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK1↓, 16,   p‑CDK1↓, 1,   CDK2↓, 24,   CDK2↑, 1,   CDK4↓, 25,   CDK4↑, 1,   p‑CDK4↓, 1,   CDK4/6↓, 1,   CDK6↓, 11,   CDK6↑, 2,   CDK8↓, 1,   CHK1↓, 2,   p‑CHK1↑, 2,   Chk2↓, 2,   p‑Chk2↓, 1,   p‑Chk2↑, 1,   ChrCon↑, 2,   Cyc↓, 2,   cycA1/CCNA1↓, 6,   cycA1/CCNA1↑, 1,   CycB/CCNB1↓, 21,   CycB/CCNB1↑, 1,   cycD1/CCND1↓, 57,   cycD1/CCND1↑, 1,   p‑cycD1/CCND1↓, 1,   CycD3↓, 1,   cycE/CCNE↓, 11,   cycE/CCNE↑, 1,   cycE1↓, 1,   E2Fs↓, 2,   E2Fs↑, 1,   GADD45A↓, 1,   Ki-67↓, 21,   mitA↑, 1,   P21↓, 6,   P21↑, 44,   p27/CDKN1B↓, 3,   p27/CDKN1B↑, 24,   pRB↓, 2,   pRB↑, 1,   p‑pRB↓, 7,   RB1↓, 1,   RB1↑, 3,   p‑RB1↓, 4,   Securin↓, 2,   TumCCA?, 1,   TumCCA↓, 5,   TumCCA↑, 116,   WEE1↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

4E-BP1↓, 1,   p‑4E-BP1↓, 3,   ALDH1A1↓, 3,   BMP2↓, 1,   BMPs↑, 2,   CD133↓, 7,   CD24↓, 3,   cFos↓, 7,   p‑cFos↓, 1,   cMYB↓, 2,   CSCs?, 1,   CSCs↓, 14,   Diff↓, 1,   Diff↑, 3,   FGF↓, 2,   Gli1↓, 1,   GREM1↓, 1,   HH↓, 1,   IGF-1↓, 10,   IGFBP3↑, 4,   JAG1↓, 1,   Jun↓, 1,   p‑Jun↑, 1,   Ki-67↓, 21,   Let-7↑, 2,   LGR5↓, 1,   Mel↓, 1,   mTORC1↓, 4,   p‑mTORC1↓, 1,   Nanog↓, 5,   Nestin↓, 3,   NICD↓, 1,   NOTCH↓, 11,   NOTCH1↓, 6,   NOTCH1↑, 1,   Piezo1↑, 1,   Shh↓, 3,   Smo↓, 1,   TAZ↓, 1,   TumCG↓, 55,   TumCP?, 1,   TumCP↓, 111,   TumCP↑, 1,   TumCP∅, 1,   tyrosinase↓, 1,   Wnt↓, 31,   Wnt/(β-catenin)↓, 9,   ZFX↓, 1,  

Migration(tgid=13) ⓘ

AEG1↓, 1,   AntiAg↓, 1,   AntiAg↑, 1,   AP-1↓, 14,   AP-1↑, 2,   BACH1↓, 1,   CA↓, 1,   Ca+2↓, 2,   Ca+2↑, 21,   Ca+2↝, 1,   mt-Ca+2↑, 1,   Cal1↑, 1,   cal2↓, 1,   cal2↑, 2,   Cdc42↓, 1,   Cdc42↑, 1,   Cofilin↓, 1,   DLC1↑, 1,   E-cadherin↓, 3,   E-cadherin↑, 29,   EM↑, 1,   EMMPRIN↓, 1,   EMT↓, 45,   EMT↑, 3,   F-actin↓, 1,   FAK↓, 18,   p‑FAK↓, 5,   p‑FAK↑, 1,   fascin↓, 2,   Fibronectin↓, 3,   Furin↓, 1,   IQGAP3↓, 1,   ITGA5↓, 3,   ITGB1↓, 4,   ITGB1↑, 1,   ITGB4↓, 1,   ITGB6↓, 1,   KRAS↓, 3,   LAMs↓, 2,   MET↓, 2,   MMP-10↓, 3,   MMP1↓, 8,   MMP13↓, 2,   MMP16↓, 1,   MMP2↓, 76,   MMP3↓, 4,   MMP7↓, 10,   MMP9↓, 89,   pro‑MMP9↓, 1,   MMP9:TIMP1↓, 1,   MMPs↓, 18,   MUC1↓, 1,   N-cadherin↓, 21,   NCAM↑, 1,   NFAT↑, 1,   pax↓, 1,   p‑pax↓, 1,   PDGF↓, 5,   Rac1↓, 2,   Rho↓, 6,   Rho↑, 1,   ROCK1↓, 2,   ROCK1↑, 2,   Sharpin↓, 1,   Slug↓, 9,   Smad1↑, 1,   Smad1↝, 1,   p‑SMAD2↓, 3,   SMAD3↓, 2,   p‑SMAD3↓, 2,   SMAD4↓, 2,   Snail↓, 16,   TET1↓, 1,   TET1↑, 1,   TGF-β↓, 13,   TGF-β↝, 1,   TGF-β1↓, 1,   TIMP1↓, 1,   TIMP1↑, 8,   TIMP2↓, 2,   TIMP2↑, 7,   TIMP3↑, 1,   TSC1↑, 1,   TSP-1↑, 3,   TumCA↓, 2,   TumCI↓, 64,   TumCI↑, 1,   TumCMig↓, 73,   TumCMig↑, 2,   TumMeta↓, 45,   TumMeta↑, 1,   Twist↓, 18,   uPA↓, 21,   uPAR↓, 2,   Vim↓, 25,   Zeb1↓, 6,   ZEB2↓, 2,   β-catenin/ZEB1↓, 38,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 52,   angioG↑, 3,   angioS↑, 1,   CD31/PECAM-1↓, 2,   ECM/TCF↓, 1,   EGR1↑, 1,   Endoglin↑, 2,   HIF-1↓, 5,   Hif1a↓, 40,   Hif1a↝, 1,   LOX1↓, 1,   NO↓, 5,   NO↑, 3,   PHDs↓, 1,   VCAM-1↓, 2,   VEGF↓, 77,   VEGFR1↓, 1,   VEGFR2/KDR/Flk1↓, 15,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 2,   CellMemb↑, 1,   CLDN1↓, 1,   CLDN1↑, 1,   CLDN2↓, 1,   CTR1↑, 1,   EPR↑, 2,   GLUT1↓, 5,   GLUT4↓, 1,   IBI↑, 1,   memfluid↓, 1,   MMP↓, 83,   MMP↑, 1,   MPT↑, 2,   NHE1↓, 2,   OCLN↑, 1,   TJ↑, 1,   TRPM7↓, 1,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CB2 / CNR2↑, 1,   CCR7↓, 1,   CD25+↑, 1,   CD4+↓, 1,   CD4+↑, 1,   CD44↓, 9,   p‑cDC2↓, 1,   COX1↓, 1,   COX2/PTGS2↓, 63,   COX2/PTGS2↑, 3,   CXCL1↓, 1,   CXCL12↓, 1,   CXCR4↓, 12,   DR4↑, 5,   FOXP3↑, 1,   HMGB1↓, 2,   ICAM-1↓, 1,   IFN-γ↓, 5,   IFN-γ↑, 4,   IL1↓, 7,   IL1↑, 1,   IL10↓, 6,   IL10↑, 2,   IL12↓, 1,   IL17↓, 1,   IL18↓, 1,   IL1α↓, 2,   IL1β↓, 14,   IL1β↑, 1,   IL2↓, 1,   IL2↑, 5,   IL22↓, 1,   IL23↓, 1,   IL4↓, 1,   IL4↑, 2,   IL6↓, 31,   IL6↑, 1,   IL8↓, 7,   IL8↑, 1,   Imm↑, 5,   Imm↝, 2,   Inflam↓, 27,   M2 MC↓, 1,   MCP1/CCL2↓, 6,   MDSCs↓, 1,   MIP2↓, 3,   NF-kB?, 1,   NF-kB↓, 114,   NF-kB↑, 4,   NF-kB↝, 3,   p‑NF-kB↑, 2,   NK cell↑, 5,   NLRP3↓, 1,   NLRP3↑, 1,   p50↓, 1,   p65↓, 8,   PD-1↓, 1,   PD-L1↓, 6,   PGD2↓, 1,   PGE2↓, 20,   PSA↓, 8,   SOCS1↑, 1,   T-Cell↑, 2,   TCF↓, 1,   TCF↑, 1,   TLR1↑, 1,   TLR2↑, 1,   TLR4↓, 3,   TLR4↑, 1,   TLR4↝, 1,   TNF-α↓, 30,   TNF-α↑, 1,   TNFRSF25/DR3/APO3/LARD/TRAMP/WSL1↑, 1,  

Cellular Microenvironment(tgid=17) ⓘ

ADAM17↓, 1,   GGT/CD224↑, 1,   IM↓, 1,   TAMS↝, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   PTN↓, 1,  

Protein Aggregation(tgid=19) ⓘ

PSEN1/PS1↓, 1,   PSEN2/PS-2↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

AR↓, 13,   COMT↓, 2,   ER-α36↓, 1,   ERα/ESR1↓, 1,   PPARα↓, 2,   PPARγ↑, 3,  

Drug Metabolism & Resistance(tgid=21) ⓘ

ABCG2↓, 3,   BioAv↓, 25,   BioAv↑, 24,   BioAv↝, 4,   BioEnh↑, 1,   chemoR↓, 1,   ChemoSen↓, 2,   ChemoSen↑, 87,   CompStab↓, 1,   CompStab↑, 1,   CompStab↝, 1,   CYP1A1↓, 3,   CYP1A1↑, 2,   CYP1A2↓, 1,   CYP1A2↑, 1,   CYP1B1↑, 1,   CYP2A3/CYP2A6↓, 1,   CYP2E1↑, 1,   CYP3A4↓, 2,   Dose?, 4,   Dose↓, 3,   Dose↑, 5,   Dose↝, 31,   Dose∅, 11,   eff?, 1,   eff↓, 27,   eff↑, 43,   eff↝, 9,   eff∅, 1,   GSTA1↑, 1,   Half-Life↓, 4,   Half-Life↑, 1,   Half-Life↝, 9,   Half-Life∅, 1,   MDR1↓, 3,   MRP1/ABCC1↓, 2,   P-gp/ABCB1↓, 10,   P-gp/ABCB1↝, 1,   P450↓, 2,   RadioS↑, 31,   selectivity?, 2,   selectivity↑, 53,   Synergy↑, 60,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

AFP↓, 1,   ALAT↓, 4,   ALAT↝, 1,   ALP↓, 2,   ALP↝, 1,   AR↓, 13,   ascitic↓, 1,   AST↓, 2,   AST↝, 1,   BMD↑, 1,   BRAF↓, 1,   BRAF↝, 1,   BRCA1↓, 2,   BRCA1↑, 1,   p‑BRCA1↑, 1,   CRP↓, 2,   E6↓, 3,   E7↓, 3,   EGFR↓, 49,   p‑EGFR↓, 4,   ERα/ESR1↓, 1,   EZH2↓, 1,   FOXM1↓, 3,   HER2/EBBR2↓, 9,   p‑HER2/EBBR2↓, 1,   hTERT/TERT↓, 9,   IL6↓, 31,   IL6↑, 1,   KRAS↓, 3,   LDH↓, 4,   LDH↑, 1,   Maspin↑, 1,   Myc↓, 4,   PD-L1↓, 6,   PSA↓, 8,   TP53↑, 2,   Tumccf↓, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiCan↑, 32,   AntiCan∅, 1,   antiD↑, 1,   antiNeop↑, 4,   AntiTum↓, 1,   AntiTum↑, 12,   cachexia↓, 1,   cardioP↑, 9,   chemoP↓, 1,   chemoP↑, 22,   chemoPv↑, 10,   ChemoSideEff↓, 7,   ChemoSideEff∅, 1,   cognitive?, 1,   hepatoP↑, 9,   neuroP↑, 5,   NP/CIPN↓, 1,   OS↑, 7,   Pain↓, 1,   QoL↑, 2,   radioP↑, 7,   Remission↑, 1,   RenoP↑, 5,   Risk↓, 9,   toxicity↓, 11,   toxicity↝, 2,   toxicity∅, 4,   TumVol↓, 15,   TumW↓, 8,   Weight∅, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↓, 1,   AntiP↑, 1,   Bacteria↓, 1,   GutMicro↑, 5,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr?, 1,   Ingr↝, 3,  
Total Targets: 949

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx?, 2,   antiOx↓, 2,   antiOx↑, 62,   ARE↓, 1,   ARE↑, 1,   Catalase↑, 31,   GCLC↑, 2,   GCLM↑, 2,   GPx↑, 20,   GPx1↑, 1,   GPx4↑, 3,   GSH↓, 1,   GSH↑, 32,   GSR↑, 4,   GSSG↓, 1,   GSTs↑, 10,   H2O2↓, 2,   H2O2↑, 1,   H2O2∅, 1,   HDL↓, 1,   HDL↑, 2,   HO-1↓, 3,   HO-1↑, 31,   Iron↓, 2,   i-Iron↓, 1,   Keap1↓, 4,   Keap1↑, 1,   Keap1↝, 1,   lipid-P?, 1,   lipid-P↓, 15,   MDA↓, 19,   MDA↑, 1,   MPO↓, 3,   NADH↓, 1,   NOX4↓, 1,   NQO1↑, 2,   Nrf1↑, 1,   NRF2↓, 1,   NRF2↑, 43,   Prx↑, 1,   RNS↓, 3,   ROS?, 1,   ROS↓, 79,   ROS↑, 1,   ROS⇅, 1,   mt-ROS?, 1,   mt-ROS↓, 1,   SOD↑, 39,   SOD1↑, 3,   SOD2↑, 1,   TAC↑, 2,   Trx↑, 1,   Trx1↑, 1,   uricA↓, 1,   VitC↑, 1,   xCT/SLC7A11↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

FTL↓, 1,   IronCh↑, 4,   IronCh↝, 1,   TfR1/CD71↓, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

compI↑, 1,   compIII↑, 1,   compV↑, 1,   DRP1/DNM1L↓, 1,   p‑DRP1/DNM1L↝, 1,   Insulin↑, 1,   MFN1↝, 1,   MFN2↑, 1,   MFN2↝, 1,   PGC-1α↑, 3,   PGC-1α↝, 1,   SIRT3↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12LOX↓, 3,   5LO↓, 5,   ACSL4↓, 1,   adiP↑, 1,   ALAT↓, 6,   AMPK↓, 1,   AMPK↑, 7,   p‑AMPK↑, 1,   ATP↑, 4,   Buty↑, 1,   cAMP↑, 3,   CRM↑, 1,   glucose↓, 1,   glucose↑, 1,   glucose↝, 2,   GlucoseCon↑, 2,   Glycolysis↑, 1,   GSK‐3β↓, 6,   GSK‐3β↑, 2,   p‑GSK‐3β↑, 2,   HMG-CoA↓, 1,   LDL↓, 3,   lipidLev↓, 1,   NADPH↓, 2,   SCFAs↑, 1,   SIRT1↑, 3,  

Cell Death(tgid=5) ⓘ

AIF↓, 1,   APAF1↓, 1,   Apoptosis↓, 8,   BAD↓, 1,   BAX↓, 3,   Bcl-2↑, 2,   Bcl-xL↑, 1,   Casp3↓, 12,   Casp3∅, 1,   Casp6↓, 1,   Casp9↓, 4,   Casp9∅, 1,   Cyt‑c∅, 2,   Fas↓, 1,   Ferroptosis↓, 3,   iNOS↓, 15,   iNOS↑, 2,   necrosis↓, 2,   p38↓, 8,   p38↑, 2,   p‑p38↓, 6,  

Kinase & Signal Transduction(tgid=6) ⓘ

Akt↓, 3,   Akt↑, 18,   p‑Akt↓, 1,   p‑Akt↑, 5,   e-Akt↑, 1,   Akt2↓, 1,   AMPKα↑, 1,   CREB↓, 1,   CREB↑, 8,   p‑CREB↑, 4,   EGFR↓, 1,   ERK↓, 29,   ERK↑, 31,   p‑ERK↓, 12,   p‑ERK↑, 11,   e-ERK↑, 1,   HGF/c-Met↑, 1,   IKKα↓, 2,   IKKα↑, 1,   p‑IKKα↓, 3,   IκB↓, 1,   p‑IκB↓, 1,   JAK2↓, 1,   JNK↓, 10,   JNK↑, 1,   p‑JNK↓, 6,   p‑JNK↑, 2,   MAPK↓, 18,   MAPK↑, 7,   p‑MAPK↓, 1,   p‑MEK↓, 1,   p‑MEK↑, 1,   mTOR↓, 2,   mTOR↑, 4,   P70S6K↓, 1,   p‑P70S6K↑, 1,   PI3K↓, 3,   PI3K↑, 11,   p‑PI3K↑, 1,   PKA↑, 3,   PKCδ↓, 2,   PKCδ↑, 2,   PP2A↑, 1,   PTEN↓, 2,   PTEN↑, 1,   Raf↓, 1,   STAT3↓, 4,   STAT3↑, 1,   p‑STAT3↑, 1,   STAT4↓, 1,   STAT5↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 2,   ATF2↑, 1,   p‑cJun↓, 1,   p‑cMyc↑, 1,   FOXO1↝, 1,   FOXO3↑, 1,   ac‑H3↑, 1,   ac‑H4↑, 1,   HDAC↓, 1,   HDAC2↓, 1,   HOTAIR↑, 1,   other↓, 3,   other↑, 2,   other↝, 8,   tumCV∅, 1,  

Protein Folding & ER Stress(tgid=8) ⓘ

CHOP/DDIT3↓, 1,   CHOP/DDIT3↑, 1,   GRP78/BiP↓, 1,   GRP78/BiP↑, 1,   GRP94↑, 1,   HSP70/HSPA5↓, 1,   HSP70/HSPA5↑, 2,   HSP90↑, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

Beclin-1/ATG6↓, 1,   Beclin-1/ATG6↑, 1,   LC3II↑, 1,   p62↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 4,   P53↓, 1,   PARP∅, 1,   PARP1↓, 1,   PCNA↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

CDK2↓, 1,   CDK4↓, 1,   CDK5↓, 1,   cycD1/CCND1↓, 1,   cycE/CCNE↓, 1,   P21↓, 1,   RB1↓, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

BMP2↑, 1,   Diff↑, 1,   Diff↝, 1,   HH↓, 1,   IGF-1↑, 1,   neuroG↑, 1,   STAT1↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 9,   AP-1↓, 3,   ARG1/2↑, 1,   Ca+2↓, 4,   Ca+2↝, 1,   p‑Cofilin↓, 1,   COL1↓, 2,   E-cadherin↑, 1,   EMT↓, 1,   Fibrosis↓, 1,   heparanase↑, 1,   MLC2/MYL9↝, 1,   MMP13↓, 2,   MMP3↓, 1,   MMP9↓, 4,   N-cadherin↑, 1,   p‑Rac1↓, 1,   Rho↓, 2,   ROCK1↓, 1,   p‑Smad1↑, 1,   SMAD2↓, 1,   SMAD3↓, 1,   p‑SMAD5↑, 1,   p‑T-cadherin↓, 1,   TGF-β1↓, 2,   TGF-β1↑, 1,   TIMP1↓, 1,   TregCell↑, 1,   Vim↓, 1,   α-SMA↓, 5,   β-catenin/ZEB1↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 1,   angioG↑, 2,   CD31/PECAM-1↓, 1,   CD31/PECAM-1↑, 1,   E-sel↓, 1,   eNOS↑, 2,   HIF-1↓, 1,   NO↓, 10,   NO↑, 2,   VCAM-1↓, 8,   VEGF↓, 1,   VEGF↑, 3,  

Barriers & Transport(tgid=15) ⓘ

BBB?, 1,   BBB↑, 11,   BBB↝, 2,   CLDN4↑, 1,   GastroP↑, 1,   GLUT1↑, 1,   GLUT2↑, 1,   GLUT4↑, 3,   H+/K+-ATPase↓, 1,   IBI↑, 2,   MMP↑, 8,   MUC19↓, 1,   MUC2↓, 1,   MUC5AC↓, 1,   OCLN↑, 2,   OCLN↝, 1,   TJ↑, 3,   TRPM7↓, 1,   ZO-1↑, 2,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CB2 / CNR2↑, 1,   CCL11↓, 1,   CD25+↓, 1,   CD69↓, 1,   COX1↓, 3,   COX2/PTGS2↓, 21,   COX2/PTGS2↑, 1,   CTLA-4↓, 1,   Eos↓, 1,   HMGB1↓, 2,   ICAM-1↓, 4,   IFN-γ↓, 3,   IL1↓, 2,   IL10↓, 2,   IL10↑, 2,   IL17↓, 3,   IL18↓, 1,   IL1β↓, 20,   IL2↓, 2,   IL2↑, 1,   IL23↓, 1,   IL4↓, 3,   IL4↑, 1,   IL6?, 1,   IL6↓, 23,   IL8↓, 3,   Imm↑, 7,   Imm⇅, 1,   Inflam↓, 79,   pol-M2 MC↑, 1,   Macrophages↓, 1,   MCP1/CCL2↓, 2,   MyD88↓, 1,   Neut↓, 1,   NF-kB↓, 42,   p‑NF-kB↓, 3,   NLRP3↓, 4,   p‑p50↓, 1,   p65↓, 1,   p‑p65↓, 2,   PGE2↓, 5,   PGE2↑, 1,   RAGE↓, 2,   Th1 response↓, 2,   Th17↓, 1,   Th2↑, 2,   TLR2↓, 1,   TLR4↓, 7,   TNF-α↓, 28,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5HT↓, 1,   5HT↑, 1,   AChE↓, 11,   ADAM10↑, 1,   BChE↓, 3,   BDNF↑, 12,   BDNF∅, 1,   GABA↑, 1,   NGF↑, 1,   PSD95↑, 1,   TPH1↓, 1,   TrkB↑, 3,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 2,   APP↓, 4,   Aβ↓, 16,   Aβ↑, 1,   BACE/β-secretase↓, 3,   IDE↑, 1,   tau↓, 3,   p‑tau↓, 4,   XO↝, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

ACE/ACE1↓, 1,   ACE2↓, 1,   ERβ/ESR2↑, 1,   Estro↓, 1,   GLP-1R↑, 1,   NR1H4↑, 1,   PPARα↑, 1,   PPARγ↓, 1,   PPARγ↑, 3,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 16,   BioAv↑, 27,   BioAv↝, 18,   BioEnh↑, 3,   Dose?, 1,   Dose↑, 1,   Dose↝, 7,   eff↓, 2,   eff↑, 9,   GSTA1↑, 2,   Half-Life↓, 1,   Half-Life↑, 2,   Half-Life↝, 6,   P-gp/ABCB1↓, 1,   Synergy↑, 3,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 6,   ALP↓, 2,   AST↓, 8,   BloodF↑, 1,   BMD↑, 2,   BP↓, 4,   BP↝, 1,   creat↓, 2,   CRP↓, 2,   EGFR↓, 1,   hs-CRP↓, 1,   IL6?, 1,   IL6↓, 23,   IRes↝, 1,   LDH↓, 3,   LDH↑, 1,   NOS2↓, 1,   RAGE↓, 2,   Urea↓, 1,  

Functional Outcomes(tgid=23) ⓘ

Analgesic↑, 2,   AntiAge↑, 1,   antiAll↑, 9,   AntiArt↑, 4,   AntiCan↑, 12,   antiCG↑, 1,   AntiDiabetic↓, 1,   AntiDiabetic↑, 15,   antiPs↑, 1,   AntiTum↑, 3,   cardioP↑, 21,   CardioT↓, 1,   chemoP↑, 5,   chemoPv↑, 3,   cognitive↓, 1,   cognitive↑, 21,   diuretic↑, 2,   hepatoP↓, 1,   hepatoP↑, 21,   Learn↑, 1,   memory↑, 19,   motorD↑, 3,   Mucositis↓, 1,   neuroP?, 1,   neuroP↑, 56,   Obesity↓, 6,   Pain↓, 3,   radioP↑, 1,   RenoP↑, 9,   Strength↑, 1,   Stroke↓, 3,   toxicity↓, 12,   toxicity↑, 1,   toxicity↝, 2,   toxicity∅, 3,   Wound Healing↑, 2,  

Infection & Microbiome(tgid=24) ⓘ

AntiFungal↑, 1,   AntiP↑, 1,   AntiViral↑, 9,   Bacteria↓, 13,   Diar↓, 1,   GutMicro↑, 9,   Inf↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 1,   Ingr↝, 7,  
Total Targets: 437

Scientific Paper Hit Count for: ERK, ERK signaling
16 Berberine
16 Curcumin
15 Fisetin
15 Quercetin
13 Sulforaphane (mainly Broccoli)
12 Silymarin (Milk Thistle) silibinin
11 Shikonin
10 EGCG (Epigallocatechin Gallate)
10 Magnetic Fields
9 Apigenin (mainly Parsley)
9 Kaempferol
9 Thymoquinone
8 Luteolin
8 Baicalein
7 Artemisinin
7 Caffeic acid
7 Formononetin
6 Radiotherapy/Radiation
6 Propolis -bee glue
6 Honokiol
6 Isobavachalcone
6 Morin
6 Licochalcone A
6 Lycopene
5 Alpha-Lipoic-Acid
5 Chrysin
5 Piperine
5 Resveratrol
4 Silver-NanoParticles
4 Allicin (mainly Garlic)
4 Astaxanthin
4 Benzyl isothiocyanate
4 Carvacrol
4 Emodin
4 Fucoidan
4 Garcinol
4 phytic acid, Inositol hexakisphosphate
4 isoorientin
4 Magnolol
4 Matrine
4 Rosmarinic acid
4 Vitamin K2
3 Cisplatin
3 Berbamine
3 Boswellia (frankincense)
3 Chlorogenic acid
3 Cynaropicrin
3 Paclitaxel/Taxol
3 Ferulic acid
3 Hyperoside
3 Inositol
3 methylseleninic acid
3 Phenethyl isothiocyanate
3 Phycocyanin
3 Piperlongumine
3 Ursolic acid
3 Vitamin C (Ascorbic Acid)
2 Andrographis
2 Ashwagandha(Withaferin A)
2 beta-glucans
2 Beta-Caryophyllene
2 Betulinic acid
2 Bromelain
2 Boron
2 Zinc
2 Capsaicin
2 Thymol-Thymus vulgaris
2 chaetocin
2 Crocetin
2 Cucurbitacin
2 Deguelin
2 Dandelion Root
2 Flaxseed/Linseed
2 5-fluorouracil
2 Gambogic Acid
2 Geraniol
2 Ginger/6-Shogaol/Gingerol
2 Ginkgetin
2 isoquercitrin
2 Licorice
2 Lutein
2 Magnetic Field Rotating
2 Myricetin
2 Nimbolide
2 Patchouli Oil (Pogostemon cablin)
2 Phenylbutyrate
2 Pterostilbene
2 Sanguinarine
2 Salvia miltiorrhiza
2 Urolithin
2 Vitexin
1 1,8-Cineole
1 3-bromopyruvate
1 Camptothecin
1 Allyl isothiocyanate
1 alpha Linolenic acid
1 Anethole/trans-Anethole
1 Ascorbyl Palmitate
1 Trastuzumab
1 Baicalin
1 Biochanin A
1 Bacopa monnieri
1 Black Rice, Oryza sativa
1 brusatol
1 α-Bisabolol / Chamomile oil
1 Centella asiatica / Gotu kola → asiaticoside
1 Chlorophyllin
1 Cinnamon
1 Citric Acid
1 Coenzyme Q10
1 Vitamin E
1 Copper and Cu NanoParticles
1 Photodynamic Therapy
1 Bicalutamide
1 Dihydrocaffeic Acid
1 gefitinib, erlotinib
1 Docosahexaenoic Acid
1 Dipyridamole
1 Ellagic acid
1 Ginkgo biloba-EGb 761
1 eicosapentaenoic acid
1 Evodiamine
1 flavonoids
1 Metformin
1 Gallic acid
1 Ginkgo biloba
1 Genistein (soy isoflavone)
1 Ginseng
1 Graviola
1 Grapeseed extract
1 Hydrogen Gas
1 epipolythiodioxopiperazine / epipolythiopiperazine-2,5-dione
1 Huperzine A/Huperzia serrata
1 Isoliquiritigenin
1 Isorhamnetin
1 Juglone
1 Mung Bean Sprouts
1 L-Theanine
1 Lasiodin
1 Lemongrass Extract/Citral
1 SDG/lignans
1 Linalool
1 mebendazole
1 Methyl Jasmonate
1 vp16, etoposide
1 Methyl salicylate / Sweet Birch oil
1 Magnesium
1 Melatonin
1 Moringa oleifera
1 Mushroom Lion’s Mane, Hericium erinaceus
1 Naringin
1 Niclosamide (Niclocide)
1 Oleocanthal
1 Oxygen, Hyperbaric
1 SonoDynamic Therapy UltraSound
1 Hyperthermia
1 Purple Corn / Purple Maize
1 Plumbagin
1 Salvia officinalis
1 Aromatherapy
1 Aflavin-3,3′-digallate
1 Tomatine
1 Turmerones
1 Isovitexin
1 Zyflamend
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:105  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page